A New Era in Schizophrenia Care: National Council for Mental Wellbeing and Bristol Myers Squibb Collaborate to Advance Evidence-Based Care Models Life Science Investing
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates Life Science Investing
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Life Science Investing
Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update Life Science Investing
NurExone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement Life Science Investing
Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity Life Science Investing
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment Life Science Investing
PharmaTher Introduces PatchPrint With Provisional Patent Filing and Commercialization Strategy for Microneedle Patches Life Science Investing
Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions Life Science Investing
